Back HIV/AIDS

HIV / AIDS

Mild Neurological Impairment Is Common During Early HIV Infection

People with HIV infection often have neurological signs and symptoms very soon after becoming infected -- even before they develop antibodies that show up on a test -- but these are typically mild to moderate and resolve after starting effective antiretroviral therapy (ART), according to a study published in the June 10 advance online edition of Neurology. These findings provide further evidence for starting treatment as soon as possible after HIV diagnosis.

alt

HIV Treatment Reduces HIV Transmission by 77% among South African Couples

Antiretroviral treatment reduced the risk of HIV transmission by 77% in serodiscordant couples in rural South Africa, a population-based study carried out in the province of KwaZulu-Natal has shown. The findings were recently published in the advance online edition of Clinical Infectious Diseases. The investigators say that their findings provide a real-life estimate of the impact of antiretroviral treatment on HIV transmission under normal community conditions.

alt

Many U.S. Communities Vulnerable to HIV Outbreaks Due to Unsafe Opioid Injection

Research published recently in the online edition of the Journal of Acquired Immune Deficiency Syndromes has identified the jurisdictions in the U.S especially vulnerable to the rapid spread of HIV or hepatitis C virus (HCV) due to unsafe injection drug use. A total of 220 countries in 26 states had a high level of vulnerability, with factors associated with unsafe injecting including unemployment, and poverty, and high rates of death due to drug overdose.

alt

ART Reduces Opportunistic Illnesses in Children and Adults with HIV

A pair of comprehensive reviews supported by the World Health Organization (WHO) have found that prompt initiation of antiretroviral therapy (ART) is associated with a lower risk of developing opportunistic infections and other HIV-related illnesses in children and adults living with HIV. Both reviews were published in the June 15 edition of Clinical Infectious Diseases.

alt

AIDS 2016: International AIDS Conference Coming Up in Durban

The 21st International AIDS Conference (AIDS 2016) will take place July 18-22 in Durban, South Africa, 16 years after the groundbreaking conference in the same city that put the spotlight on global access to new life-saving treatment for people living with HIV and AIDS. This year's theme -- Access, Equity, Rights Now -- recognizes the barriers that still need to be overcometo achieve universal access. HIVandHepatitis.com and collaborator Aidsmap.com will provide comprehensive on-site coverage starting July 18. Follow @HIVandHepatitison Twitter and see our AIDS 2016 conference page (coming soon) or Facebook page for the latest news.

alt

Retention in Care Drives Adherence in PrEP Implementation Programs

The proportion of gay and bisexual men who started and remained on Truvada for pre-exposure prophylaxis (PrEP) varied in real-world implementation programs in 3 mid-size U.S. cities, but retention in care was "consistently suboptimal," according to a study described in the June 13 online edition of the Journal of the International AIDS Society. Among those who did remain in care, however, adherence was good.

alt

AIDS 2016: Second Durban Declaration Highlights Key Advances and Barriers

In advance of the 21st International AIDS Conference (AIDS 2016), starting July 18 in Durban, South Africa, the International AIDS Society has released the Second Durban Declaration, highlighting the 5 key scientific advances in the HIV field and 5 key structural barriers that have yet to be overcome.

alt